Cystinuria
Authors: FREDERIC C. BARTTER
Journal: Annals of Internal Medicine (1965)

Clinical Staff Conference1 April 1965CystinuriaCombined Clinical Staff Conference at the National Institutes of HealthFREDERIC C. BARTTER, M.D., MYRON LOTZ, M.D., SAMUEL THIER, M.D., LEON E. ROSENBERG, M.D., JOHN T. POTTS JR., M.D.FREDERIC C. BARTTER, M.D.Search for more papers by this author, MYRON LOTZ, M.D.Search for more papers by this author, SAMUEL THIER, M.D.Search for more papers by this author, LEON E. ROSENBERG, M.D.Search for more papers by this author, JOHN T. POTTS JR., M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-62-4-796 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDr. Frederic C. Bartter: The fascination presented by the problem of cystinuria is apparent when one considers that it is being studied in three of the National Institutes of Health, namely, National Institute of Arthritis and Metabolic Diseases, National Cancer Institute, and National Heart Institute. This represents a symposium in which the studies from each of the Institutes will be briefly summarized. To illustrate the point of departure from which all three groups have begun their studies, it is appropriate to review briefly the history of cystinuria. We shall then present a patient who has made contributions to the studies...References1. WOLLASTON WH: On cystic oxide, a new species of urinary calculus. Phil. Trans. Roy. Soc. London 100: 223, 1810. CrossrefGoogle Scholar2. UDRÁNSZKYBAUMANN LVE: Weitere beiträge zur kenntniss der cystinurie. Hoppe-Seyler Z. Physiol. Chem. 15: 77, 1891. Google Scholar3. LOEWYNEUBERG AC: Uber cystinurie. Hoppe-Seyler Z. Physiol. Chem. 43: 338, 1904. CrossrefGoogle Scholar4. BRANDCAHILL EGF: Further studies on metabolism of sulfur compounds in cystinuria. Proc. Soc. Exp. Biol. Med. 31: 1247, 1934. CrossrefGoogle Scholar5. DENTSENIORWALSHE CEBJM: The pathogenesis of cystinuria. II. Polarographic studies of the metabolism of sulphur-containing amino-acids. J. Clin. Invest. 33: 1216, 1954. CrossrefMedlineGoogle Scholar6. MILNEASATOOREDWARDSLOUGHRIDGE MDAMKDLW: The intestinal absorption defect in cystinuria. Gut 2: 323, 1961. CrossrefMedlineGoogle Scholar7. ASATOORLACEYLONDONMILNE AMBWDRMD: Amino acid metabolism in cystinuria. Clin. Sci. 23: 285, 1962. MedlineGoogle Scholar8. DENTROSE CEGA: Amino acid metabolism in cystinuria. Quart. J. Med. 20: 205, 1951. MedlineGoogle Scholar9. YEHFRANKLDUNNPARKERHUGHESGYÖRGY HLWMSPBP: The urinary excretion of amino acids by a cystinuric subject. Amer. J. Med. Sci. 214: 507, 1947. CrossrefMedlineGoogle Scholar10. STEIN WH: Excretion of amino acids in cystinuria. Proc. Soc. Exp. Biol. Med. 78: 705, 1951. CrossrefMedlineGoogle Scholar11. DOOLANHARPERHUTCHINALPEN PDHAMEEI: Renal clearance of lysine in cystinuria. Pathogenesis and management of this abnormality. Amer. J. Med. 23: 416, 1957. CrossrefMedlineGoogle Scholar12. ROBSONROSE EBGA: Effect of intravenous lysine on renal clearances of cystine, arginine and ornithine in normal subjects, in patients with cystinuria and Fanconi syndrome and their relatives. Clin. Sci. 16: 75, 1957. MedlineGoogle Scholar13. BRIGHAMSTEINMOORE MPWHS: The concentrations of cysteine and cystine in human blood plasma. J. Clin. Invest. 39: 1633, 1960. CrossrefMedlineGoogle Scholar14. WEBBERBROWNPITTS WAJLRF: Interactions of amino acids in renal tubular transport. Amer. J. Physiol. 200: 380, 1961. CrossrefMedlineGoogle Scholar15. FRIMPTERHORWITHFURTHFELLOWSTHOMPSON GWMEREDD: Inulin and endogenous amino acid renal clearances in cystinuria: evidence for tubular secretion. J. Clin. Invest. 41: 281, 1962. CrossrefMedlineGoogle Scholar16. FRIMPTER GW: Cystinuria: metabolism of the disulfide of cysteine and homocysteine. J. Clin. Invest. 42: 1956, 1963. CrossrefMedlineGoogle Scholar17. CRAWHALLSCOWENWATTS JCEFRW: Effect of penicillamine on cystinuria. Brit. Med. J. 1: 588, 1963. CrossrefMedlineGoogle Scholar18. ROSENBERGDOWNINGSEGAL LESJS: Competitive inhibition of dibasic amino acid transport in rat kidney. J. Biol. Chem. 237: 2265, 1962. CrossrefMedlineGoogle Scholar19. FOXTHIERROSENBERGRISERSEGAL MSLEWS: Evidence against a single renal transport defect in cystinuria. New Eng. J. Med. 270: 556, 1964. CrossrefMedlineGoogle Scholar20. FRIMPTER GW: Disulfide of 1-cysteine and 1-homocysteine in urine of patients with cystinuria. J. Biol. Chem. 236: PC 51, 1961. CrossrefGoogle Scholar21. UDRÁNSKYBAUMANN LVE: Ueber das vorkommen von diaminen, sogenannten ptomainen, bei cystinurie. Hoppe-Seyler Z. Physiol. Chem. 13: 562, 1889. Google Scholar22. BRANDCAHILLHARRIS EGFMM: Cystinuria. II. The metabolism of cysteine, methionine and glutathione. J. Biol. Chem. 109: 69, 1935. CrossrefGoogle Scholar23. THIERFOXSEGALROSENBERG SMSLE: Cystinuria: in vitro demonstration of an intestinal transport defect. Science 143: 482, 1964. CrossrefMedlineGoogle Scholar24. ROSENBERGDOWNING LESJ: Transport of cystine and the dibasic amino acids by leukocytes from normal subjects and patients with cystinuria. J. Clin. Invest. 43: 1290, 1964. Google Scholar25. BECKERGREEN FFH: Incorporation of cystine and lysine by normal and "cystinuric" leukocytes. Proc. Soc. Exp. Biol. Med. 99: 694, 1958. CrossrefMedlineGoogle Scholar26. AMES GF: Uptake of amino acids by Salmonella typhimurium. Arch. Biochem. 104: 1, 1964. CrossrefMedlineGoogle Scholar27. DENTSENIOR CEB: Studies on the treatment of cystinuria. Brit. J. Urol. 27: 317, 1955. CrossrefMedlineGoogle Scholar28. KOLTHOFFSTRICKSKAPOOR IMWRC: Equilibrium constants of exchange reactions of cystine with glutathione and with thioglycolic acid both in the oxidized and reduced state. J. Amer. Chem. Soc. 77: 4733, 1955. CrossrefGoogle Scholar29. ELDJARNPIHL LA: On the mode of action of X-ray protective agents. II. Interaction between biologically important thiols and disulfides. J. Biol. Chem. 225: 499, 1957. CrossrefMedlineGoogle Scholar30. LEWIS HB: Cystinuria. A review of some recent investigations. Yale J. Biol. Med. 4: 437, 1932. MedlineGoogle Scholar31. SMITHKOLBHARPER DRFOHA: Management of cystinuria and cystine-stone disease. J. Urol. 81: 61, 1959. CrossrefMedlineGoogle Scholar32. COLLISSLEVIMILNE JEAJMD: Stature and nutrition in cystinuria and Hartnup's disease. Brit. Med. J. 1: 590, 1963. CrossrefMedlineGoogle Scholar33. WEINBERGTABENKIN SRPA: Observations on therapy of cystine calculus disease. Arch. Intern. Med. (Chicago) 90: 850, 1952. CrossrefGoogle Scholar34. STERNLIEBSCHEINBERG IIH: Penicillamine therapy for hepatolenticular degeneration. JAMA 189: 748, 1964. CrossrefMedlineGoogle Scholar35. GOLDBERGSMITHLOCHHEAD AJAAC: Treatment of lead poisoning with oral penicillamine. Brit. Med. J. 1: 1270, 1963. CrossrefMedlineGoogle Scholar36. FELLERSSHAHIDI FXNT: The nephrotic syndrome induced by penicillamine therapy. Amer. J. Dis. Child 98: 669, 1959. Google Scholar37. CORCOSSOLER-BECHARAMAYERFREYBERGGOLDSTEINJAFFE JMJKRHRI: Neutrophilic agranulocytosis during administration of penicillamine. JAMA 189: 265, 1964. CrossrefMedlineGoogle Scholar38. SHERWINBECKMCKENNA ALITRD: The course of Wilson's disease (hepatolenticular degeneration) during pregnancy and after delivery. Canad. Med. Ass. J. 83: 160, 1960. MedlineGoogle Scholar39. BOULDING JE: Treatment of Wilson's disease with d-penicillamine, in Wilson's Disease, Some Current Concepts, edited by WALSH, J. M., and CUMMINGS, J. N., Blackwell Scientific Publications, Oxford, England, 1961, p. 224. Google Scholar40. LEVINE BB: Formation of d-penicillamine-cysteine mixed disulphide by reaction of d-benzylpenicilloic acid with cystine. Nature (London) 187: 940, 1960. CrossrefMedlineGoogle Scholar41. GERMAN JL: Discussion, in Metal Binding in Medicine, edited by SEVEN, M. J., and JOHNSON, L. A., J. B. Lippincott and Co., Philadelphia, 1960, p. 304. Google Scholar42. LEVINLOTZ SM: Unpublished observations. Google Scholar43. HEYLHARRISFOLKERS DSAK: The chemistry of vitamin B6. VI. Pyridoxylamino acids. J. Amer. Chem. Soc. 70: 3429, 1948. CrossrefMedlineGoogle Scholar44. KUCHINSKASDU VIGNEAUD EJV: An increased vitamin B6 requirement in the rat on a diet containing 1-penicillamine. Arch. Biochem. 66: 1, 1957. CrossrefMedlineGoogle Scholar45. KUCHINSKASHORVATHDU VIGNEAUD EJAV: An anti-vitamin B6 action of 1-penicillamine. Arch. Biochem. 68: 69, 1957. CrossrefMedlineGoogle Scholar46. JAFFEALTMANMERRYMAN IAKP: The antipyridoxine effect of penicillamine in man. J. Clin. Invest. 43: 1869, 1964. CrossrefMedlineGoogle Scholar47. SMITHMILLER ADJW: Treatment of inorganic mercury poisoning with n-acetyl-d, 1-penicillamine. Lancet 1: 640, 1961. CrossrefGoogle Scholar48. HmscHMANFEINGOLDBOYLEN SZMG: Mercury in house paint as a cause of aerodynia: effect of therapy with n-acetyl-d, 1-penicillamine. New Eng. J. Med. 269: 889, 1963. CrossrefMedlineGoogle Scholar49. APOSHIANAOSHIAN HVMM: N-acetyldl-penicillamine, new oral protective agent against lethal effects of mercuric chloride. J. Pharmacol. Exp. Ther. 126: 131, 1959. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Bethesda, MarylandThis is an edited transcription of a combined clinical staff conference at the Clinical Center, Bethesda, Md., by the National Heart Institute, National Institutes of Health, U. S. Public Health Service, Bethesda, Md.Requests for reprints should be addressed to Frederic C. Bartter, M.D., National Heart Institute, Bldg. 10, Room 8-N-214, National Institutes of Health, Bethesda, Md. 20014. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPercutaneous Instillation of Chemolytic, Chemotherapeutic, and Antifungal AgentsDNA and Other Strands: The Making of a Human GeneticistPercutaneous Instillation of Chemolytic, Chemotherapeutic, and Antifungal AgentsBladder and renal stones: management and treatmentContemporary Management of CystinuriaCYSTINE CALCULIClinical Effect of Captopril on the Formation and Growth of Cystine CalculiCystinuriaRelationship of Nutritional Factors to the Cause, Dissolution, and Prevention of Canine UrolithsAzarbine-homocystinemia-thrombosis in historical perspectiveManagement of the Patient with CystinuriaDer ZystinsteinManagement of Cystine Nephrolithiasis with Alpha-MercaptopropionylglycineThiol-disulfide interchange between cystine and N-2-mercaptoethyl-1,3-diaminopropane as a potential treatment for cystinuriaHomozygous Cystinuria—Evaluation of 35 PatientsHomocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injuryMedical Treatment for Cystinuria: Case Material and ResultsAcid Dissociation and Metal Complex Formation Constants of Penicillamine, Cysteine, and Antiarthritic Gold Complexes at Simulated Biological ConditionsCystinuria and Cystine LithiasisPractical Guidelines for the Diagnosis and Management of Calcium UrolithiasisThe Management of Cystinuria in 1976EXTRAPOLATION OF MECHANISM STUDIES ON GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE TO THE TREATMENT OF AVIAN MUSCULAR DYSTROPHYStudies on d-penicillamine metabolism in cystinuria and rheumatoid arthritis: Isolation of S-methyl-D-penicillamineUrinary tract stone disease classic studiesRenal transport of amino acidsGrundsätzliches zur Funktion von BiomembranenRenal Transport of Amino AcidsGenetic ScreeningRapid Screening Methods for the Detection of Inherited and Acquired AminoacidopathiesHuman Genetics of Membrane Transport with Emphasis on Amino AcidsAMINOACIDS, AMINES, AND RELATED COMPOUNDSRetinal Hemorrhages During Penicillamine Therapy of CystinuriaFamilial Iminoglycinuria“Disappearance” of cystinuria in a patient treated with prolonged low methionine dietExcretion of Trace Elements in Two Penicillamine-treated Cases of CystinuriaQuantitative Determination of Thiols and Disulphides in Urine by Means of Ellman's Reagent and Thiolated Sephadex and its Application in CystinuriaPenicillamine Therapy for Rheumatoid Lung Disease: Effects on Protein Sulphydryl GroupsSeparation of cystine, penicillamine disulfide and cysteine-penicillamine mixed disulfide by automatic amino acid analysisD-Penicillamine Therapy in CystinuriaStone Dissolution in Vivo and Control of Cystinuria with D-PenicillamineA New Look at Cystinuria 1 April 1965Volume 62, Issue 4Page: 796-822KeywordsArthritisExcretionHeart diseasesMedical servicesMetabolic disordersMucous membranesPrevention, policy, and public health Issue Published: 1 April 1965 PDF downloadLoading ...